AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 NOV 3 - (NewsRx.com & NewsRx.net) -- An interfering vaccine is a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing.
According to a study from England, "Infection with human influenza A virus can reach cataclysmic levels, with 40 or more million deaths arising from the 1918 pandemic. Preventative and therapeutic measures have improved since that time, but new approaches are needed. Here, we describe one such new approach-the interfering vaccine, which has two activities: it prophylactically prevents influenza, and at the same time converts an otherwise lethal infection into one that is avirulent and immunizing."
"Mice treated in this way develop a solid immunity that protects them against a subsequent challenge with homologous virus, and to a lesser extent from challenge with heterologous influenza A viruses," said Simon Noble and colleagues at the University of Warwick. "The interfering vaccine comprises non-infectious, defective interfering (DI) influenza A virus. Prophylaxis is mediated directly by DI RNA, and results from interference with the replication of the infecting virus. However, interference is incomplete, and there is sufficient wild-type virus multiplication to stimulate a virus-specific natural immunity."
"As the replication mechanism is common to all influenza A viruses, an ...
Source: HighBeam Research, Interfering vaccine converts virulent infection into immunizing one.